The HIV epidemic in Eastern Europe and Russia is large and not well-controlled. To
describe the more recent molecular epidemiology of HIV-1, transmitted drug resistance, and …

In Russia, antiretroviral therapy (ART) coverage has significantly increased, which, in the
absence of routine genotyping testing, could lead to an increase in HIV drug resistance …

Of the 12 million people who inject drugs worldwide, 13% live with HIV. Whether opioid use
impacts HIV pathogenesis and latency is an outstanding question. To gain insight into …

Internally displaced persons are often excluded from HIV molecular epidemiology
surveillance due to structural, behavioral, and social barriers in access to treatment. We test …

Approximately 35% of persons with diagnosed HIV infection in the United States do not have
a suppressed viral load (Centers for Disease Control and Prevention, 2022), underscoring …

Increasing HIV drug resistance is an important public health concern. The current study
aimed to assess HIV drug resistance among people who live with HIV (PLWH) experiencing …

Previous studies reported human immunodeficiency virus (HIV) could enhance human
papillomavirus (HPV)‐induced cervical cancer. Therefore, the burden of cervical cancer …

The HIV/AIDS epidemic in Russia is among the fastest growing in the world. HIV epidemic
burden is non-uniform in different Russian regions and diverse key populations. An …

The increased antiretroviral therapy (ART) coverage of patients in the absence of routine
genotyping tests and in the context of active labor migration highlight the importance of HIV …

The CRF02_AG and sub-subtype A6 are currently the predominant HIV-1 variants in the
Republic of Uzbekistan, but little is known about their time-spatial clustering patterns in high …